U.S. Yields Testing Support Ahead Of FOMC Meeting
We continue to see signs of improving risk appetites alongside healthy market dynamics. As a result, our outlook remains constructive.
201 Views
U.S. Equity Strategy: Risk-On Rotations Vs. Weaker Seasonality; Russell 2000, Biotech, EM Improving
We are seeing signs of rotations back into more risk-on areas of the equity market -- a bullish sign for the broad market. Add to biotech, small-...
249 Views
Upgrading U.S. Staples To Market Weight
Despite mild deterioration in market dynamics, there are plenty of indicators that remain positive and our outlook remains constructive for the...
456 Views
Nutanix: Subscription Transition Meets Corona Virus? Huh?
This note is a followup to our deep dive on Nutanix from December. The quarter’s results were consistent with our long thesis, and the near 30%...
300 Views
Nutanix Buy This SaaS Transition at a Discount I (Fundamentals)
This case study evaluates Nutanix Inc (NTNX US)'s business fundamentals, unit economics, valuation, investors, management and culture. A 2016...
373 Views